Delivery Order SPE2DB22D3011-SPE2DB24FP8QY
- Not listed
- This federal contract award, valued at $18,010.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg Tablet UD 100s, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Fenofibrate 145 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $6,945.55 and a period of performance through January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through November 2026. This IDC...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,466.45, is for the delivery of Fenofibrate 145 mg tablets. It is a firm fixed-price delivery order contract with a completion date of March 12, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $19,636.30, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Fenofibrate 145 mg tablets in quantities of 90s. It is a firm-fixed-price delivery order contract with a period of performance running through March 6, 2025. The contract was awarded on March 5, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $10,834.59 firm fixed-price delivery order is for the supply of 90-count capsules of 150mg Fenofibrate, a medication used to treat high cholesterol and triglyceride levels. This award is a child contract under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which...
- This federal contract award is for the delivery of Fenofibrate 145 mg tablets in 90-count packages. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $22,636.70, and has a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $29,773.32, is for the delivery of Fenofibrate 145 mg Tablets, a prescription medication used to treat high cholesterol and triglyceride levels. The contract is a firm-fixed-price delivery order, with a period of performance through September 21, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,311.20 firm-fixed-price delivery order contract is for the supply of 4565427386 - Fenofibrate 145 MG Tablet 90s. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $7,108.03 Firm Fixed Price Delivery Order is for the supply of 4,565,907,632 units of Fenofibrate 145 mg Tablets, a prescription medication. The contract has a completion date of September 24, 2024 and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with various...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,152.00 firm fixed price contract is for the supply of fenofibrate 145 mg tablets. It is not a set-aside contract. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB24FP8QYDelivery Order
This federal contract award, valued at $9,769.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract is a Firm Fixed Price Delivery Order, with a period of performance through January 18, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 1/17/24 |